Literature DB >> 7727545

A novel polymorphism in the human acid sphingomyelinase gene due to size variation of the signal peptide region.

Q Wan1, E H Schuchman.   

Abstract

Acid sphingomyelinase (ASM) is the lysosomal enzyme required to hydrolyze sphingomyelin into ceramide and phosphocholine. In man, a deficiency of this enzymatic activity leads to Types A and B Niemann-Pick disease (NPD), a panethnic disease with a relatively high incidence among Ashkenazi Jewish individuals. Analysis of the ASM cDNA and genomic sequences revealed a unique hexanucleotide sequence, CTGG(TC)(GT), located within the signal peptide region of the ASM polypeptide (corresponding to the hydrophobic amino acid sequence LVLALALALALA). Notably, five hexanucleotide repeat units were found in the full-length cDNA, while the genomic sequence contained six, suggesting that this region of the ASM gene may be polymorphic. PCR primers were designed to amplify the repeat region and over 700 normal and NPD ASM alleles were analyzed among Ashkenazi Jewish and non-Jewish populations. Five alleles were identified corresponding to nine, seven, six, five and four hexanucleotide repeats, respectively. The allele frequencies were similar among Jewish and non-Jewish populations and no differences were found among normal individuals and Type A and B NPD patients. Thus, it does not appear to be a common cause of NPD. This intriguing repeat polymorphism should be extremely useful to researchers interested in gene identification and characterization of the chromosomal region 11p15.1-p15.4, as well as individuals interested in the biology of this important lysosomal hydrolase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7727545     DOI: 10.1016/0925-4439(95)00050-e

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Types A and B Niemann-Pick disease.

Authors:  Edward H Schuchman; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2016-12-16       Impact factor: 4.797

Review 2.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

3.  Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients.

Authors:  Laura Rodríguez-Pascau; Laura Gort; Edward H Schuchman; Lluïsa Vilageliu; Daniel Grinberg; Amparo Chabás
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

Review 4.  The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.

Authors:  E H Schuchman
Journal:  J Inherit Metab Dis       Date:  2007-07-12       Impact factor: 4.982

5.  Alleged Detrimental Mutations in the SMPD1 Gene in Patients with Niemann-Pick Disease.

Authors:  Cosima Rhein; Christiane Mühle; Johannes Kornhuber; Martin Reichel
Journal:  Int J Mol Sci       Date:  2015-06-15       Impact factor: 5.923

6.  Plasma membrane damage repair is mediated by an acid sphingomyelinase in Entamoeba histolytica.

Authors:  Fátima Ramírez-Montiel; Claudia Mendoza-Macías; Sairy Andrade-Guillén; Ángeles Rangel-Serrano; Itzel Páramo-Pérez; Paris E Rivera-Cuéllar; B Liliana España-Sánchez; Gabriel Luna-Bárcenas; Fernando Anaya-Velázquez; Bernardo Franco; Felipe Padilla-Vaca
Journal:  PLoS Pathog       Date:  2019-08-28       Impact factor: 6.823

Review 7.  Keep Your Friends Close, but Your Enemies Closer: Role of Acid Sphingomyelinase During Infection and Host Response.

Authors:  Ha-Yeun Chung; Ralf A Claus
Journal:  Front Med (Lausanne)       Date:  2021-01-21

Review 8.  Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective.

Authors:  Carolina Pinto; Diana Sousa; Vladimir Ghilas; Andrea Dardis; Maurizio Scarpa; Maria Fatima Macedo
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

9.  Sphingomyelin phosphodiesterase-1 (SMPD1) coding variants do not contribute to low levels of high-density lipoprotein cholesterol.

Authors:  Zari Dastani; Isabelle L Ruel; James C Engert; Jacques Genest; Michel Marcil
Journal:  BMC Med Genet       Date:  2007-12-18       Impact factor: 2.103

10.  Next-generation carrier screening.

Authors:  Mark A Umbarger; Caleb J Kennedy; Patrick Saunders; Benjamin Breton; Niru Chennagiri; John Emhoff; Valerie Greger; Stephanie Hallam; David Maganzini; Cynthia Micale; Marcia M Nizzari; Charles F Towne; George M Church; Gregory J Porreca
Journal:  Genet Med       Date:  2013-06-13       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.